Search bioRxiv⌕ Search

Biology subjects

Malvankar, S.

Publications and source records attributed to Malvankar, S..

2 recordsLinked to original sources

Effects of transmembrane phenylalanine residues on γ-secretase-mediated Notch-1 proteolysis

{gamma}-Secretase is a presenilin-containing intramembrane aspartyl protease complex that cleaves within the transmembrane domain (TMD) of nearly 150 substrates, with the amyloid precursor protein (APP) being the most well studied. APP cleavage by {gamma}-secretase generates amyloid {beta}-peptides (A{beta}) that pathologically deposit in Alzheimers disease. APP TMD substrate undergoes initial endoproteolysis ({varepsilon}-cleavage) followed by processive carboxypeptidase trimming of long A{beta} intermediates in [~]tripeptide intervals. Although {gamma}-secretase cleavage of Notch1 is essential in developmental biology and altered in many cancers, the processing of this cell-surface receptor is relatively understudied. Only one sequence specificity rule is known for {gamma}-secretase substrate processing: Aromatic residues such as phenylalanine are not tolerated in the P2 position with respect to any processing event on the APP TMD. Here we show using biochemical and mass spectrometry (MS) techniques that this specificity rule holds for Notch1 as well. Analysis of products from the reactions of purified enzyme complex and Notch1 TMD substrate variants revealed that P2 Phe relative to {varepsilon}-site cleavage reduced proteolysis and shifted initial cleavage N-terminally by one residue. Double Phe mutation near the {varepsilon} site resulted in reduced proteolysis with shifting to two major initial cleavage sites, one N-terminally and one C-terminally, both of which avoid Phe in the P2 position. Additionally, three natural Phe residues were mutated to corresponding residues in the APP TMD, which led to increased {varepsilon} proteolysis. Thus, Phe residues can affect the enzyme reaction rate as well as cleavage site specificity in the Notch1 TMD.

biochemistry↗

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition.

Frequent metastatic relapses in Triple-Negative Breast Cancer (TNBC) patients with residual disease is a clinical challenge, largely due to tumor heterogeneity and absence of strategies that target proliferating chemo-tolerant cells. Here, we longitudinally modeled cellular state transitions from dormant drug-tolerant persister (DTP) into proliferating drug-tolerant persister (PDTP) in cells representing all TNBC subtypes. Combining subcellular imaging with phenotypic and biochemical assays, we identified distinct and converged spectrums of alterations in TNBC-PDTPs. We show that PDTPs retain acquired resistance with increased invasion potential. Moreover, Basal-Like DTPs enter into a non-reversible mesenchymal state while luminal androgen receptor-positive gain partial-Epithelial-to-Mesenchymal Transition (EMT) with vimentin upregulation. PDTP state dwells on high autophagy with reduced glutathione and GPX4 levels, rendering it vulnerable to autophagy suppression and ferroptosis. Interestingly, we find that GPX4 negatively regulates EMT and autophagy in TNBC, and an inverse correlation of GPX4-VIM expression along with autophagy genes predicts survival in TNBC patients undergoing chemotherapy.

cancer biology↗